Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

APhA ENDORSES FULL BAN ON DRUG SAMPLING

Executive Summary

APhA ENDORSES FULL BAN ON DRUG SAMPLING as one of three resolutions adopted at a May 25 board meeting. Approving a motion to support "legislation that would ban drug product sampling," the pharmacy association is setting the foundation for any attempts to raise the topic of sampling as part of the larger Capitol Hill consideration of health care reform proposals. Sen. Kassebaum (R- Kan.) and Rep. Brewster (D-Okla.) remain interested in introducing bills to ban sampling after Congress returns from the Memorial Day recess.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS024528

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel